The wellness and longevity boom has come for a new kind of consumer: your pet. But with clinical trials still underway and questions lingering about the safety and efficacy of off-label drugs and treatments, how are owners navigating the growing industry?

On today’s Big Take podcast, Bloomberg’s Annika Inampudi and host Sarah Holder dig into the latest frontier in the predicted $165 billion market for pet spending in the US. Plus, we meet a Manhattan dog owner who’s trying just about everything to keep his furry friends healthy.

Read more: Can Your Dog Live Forever? Pet Owners Are Trying Everything

Further listening: The Underground Peptide Market Is Getting Ready to Go Mainstream

We have a special Bloomberg subscription offer for podcast listeners at Bloomberg.com/podcastoffer.

Hosted by Sarah Holder; Produced by Julia Press and Victor Swezey; Reported by Annika Inampudi and Anna Edney; Edited by Aaron Edwards and Tracey Samuelson.

Fact-checking by Rachael Lewis-Krisky and Brunella Tipismana Urbano; Engineering by Alex Sugiura.

Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

The wellness and longevity boom has come for a new kind of consumer: your pet. But with clinical trials still underway and questions lingering about the safety and efficacy of off-label drugs and treatments, how are owners navigating the growing industry?
On today&rsquo;s Big Take podcast, Bloomberg&rsquo;s Annika Inampudi and host Sarah Holder dig into the latest frontier in the predicted $165 billion market for pet spending in the US. Plus, we meet a Manhattan dog owner who&rsquo;s trying just about everything to keep his furry friends healthy.
Read more: <a href="https://www.bloomberg.com/news/features/2026-08-13/pet-owners-turn-to-rapamycin-to-help-dogs-and-cats-live-longer?srnd=undefined">Can Your Dog Live Forever? Pet Owners Are Trying Everything</a>
Further listening:&nbsp;<a href="https://podcasts.apple.com/us/podcast/big-take/id1578096201?i=1000775241443">The Underground Peptide Market Is Getting Ready to Go Mainstream</a>
We have a special Bloomberg subscription offer for podcast listeners at&nbsp;<a href="https://www.bloomberg.com/subscriptions/podcasts">Bloomberg.com/podcastoffer.</a>
Hosted by Sarah Holder; Produced by Julia Press and Victor Swezey; Reported by Annika Inampudi and Anna Edney; Edited by Aaron Edwards and Tracey Samuelson.
Fact-checking by Rachael Lewis-Krisky and Brunella Tipismana Urbano; Engineering by Alex Sugiura.
Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

Big Take

Should Your Dog Be on Peptides?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fc055395-4a1d-4c37-949c-b4bb010cf92a/transcript